Pages that link to "Q35154624"
Jump to navigation
Jump to search
The following pages link to Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis (Q35154624):
Displaying 45 items.
- Hypoxic control of metastasis (Q26749159) (← links)
- The dual role of tumor lymphatic vessels in dissemination of metastases and immune response development (Q28076945) (← links)
- Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment (Q28081431) (← links)
- Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics (Q30278668) (← links)
- IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells (Q33889122) (← links)
- Inhibition of breast cancer growth and metastasis by a biomimetic peptide (Q34545644) (← links)
- Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients. (Q35755674) (← links)
- Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes (Q36288549) (← links)
- Leptin promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-27b in human chondrosarcoma cells (Q37040086) (← links)
- Biomimetic on-a-chip platforms for studying cancer metastasis (Q37207817) (← links)
- BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer (Q37392753) (← links)
- CCL5 promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-507 in human chondrosarcoma cells (Q37392868) (← links)
- The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts (Q37519061) (← links)
- Baicalein reduces angiogenesis in the inflammatory microenvironment via inhibiting the expression of AP-1. (Q37702378) (← links)
- The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma. (Q37745788) (← links)
- The lymph node pre-metastatic niche (Q38613301) (← links)
- CD146 is required for VEGF-C-induced lymphatic sprouting during lymphangiogenesis. (Q38636009) (← links)
- An agent-based model of triple-negative breast cancer: the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxia (Q38685879) (← links)
- Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications (Q38851214) (← links)
- Heterogeneity of chemokine cell-surface receptor expression in triple-negative breast cancer (Q38860946) (← links)
- Hypoxia: Signaling the Metastatic Cascade (Q39456897) (← links)
- CXCL12 enhances angiogenesis through CXCR7 activation in human umbilical vein endothelial cells (Q40081955) (← links)
- Crosstalk between stromal components and tumor cells of TNBC via secreted factors enhances tumor growth and metastasis (Q41694184) (← links)
- Factors involved in cancer metastasis: a better understanding to "seed and soil" hypothesis (Q47101944) (← links)
- Differential osteopontin expression in human osteoblasts derived from iliac crest and alveolar bone and its role in early stages of angiogenesis (Q47554433) (← links)
- Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression (Q51304544) (← links)
- Single-cell RNA sequencing reveals gene expression signatures of breast cancer-associated endothelial cells (Q51740041) (← links)
- Lymphatic endothelial cells actively regulate prostate cancer cell invasion. (Q52871186) (← links)
- Stromal cells in breast cancer as a potential therapeutic target. (Q55016792) (← links)
- Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis. (Q55379089) (← links)
- Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression. (Q55561847) (← links)
- Lymphatic Tissue Engineering and Regeneration (Q60044455) (← links)
- Breast cancer, human immunodeficiency virus and highly active antiretroviral treatment; implications for a high-rate seropositive region (Q61818269) (← links)
- STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review (Q64056219) (← links)
- The Interplay Between Lymphatic Vessels and Chemokines (Q64118708) (← links)
- Engineering the pre-metastatic niche (Q89164779) (← links)
- Comparative Secretome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteomics (Q89433579) (← links)
- ECM1 secreted by HER2-overexpressing breast cancer cells promotes formation of a vascular niche accelerating cancer cell migration and invasion (Q90589607) (← links)
- Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy (Q90657014) (← links)
- Runx-mediated regulation of CCL5 via antagonizing two enhancers influences immune cell function and anti-tumor immunity (Q90695294) (← links)
- Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling (Q91198917) (← links)
- Implantable pre-metastatic niches for the study of the microenvironmental regulation of disseminated human tumour cells (Q92586036) (← links)
- Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma (Q92811559) (← links)
- Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers (Q93001507) (← links)
- In vitro modeling of solid tumor interactions with perfused blood vessels (Q102210939) (← links)